ARTICLE | Strategy
Digital Preclinical
How Vium is automating data collection to overhaul in vivo research practices
June 2, 2016 7:00 AM UTC
After flying under the radar for the last three years, Vium Inc. is coming out of the shadows with a technology it thinks will change the face of in vivo testing. By bringing high tech to life sciences, Vium is developing a system of digital cages and informatics systems for an almost fully automated process of conducting animal studies that it claims is more reproducible, reliable and scalable than the industry standard.
The company was formed in 2013 as Mousera Inc., and since then has been working with a select group of beta partners to develop the platform. In the last two years, it closed $30 million in series A funding from Lux Capital, Founders Fund, Data Collective, Dolby Family Ventures and Ame Cloud Ventures...